HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 12.64
+0.74 (6.22%)
At close: Mar 27, 2026
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 10.56 billion as of March 27, 2026. Its market cap has increased by 117.58% in one year.
Market Cap
10.56B
Enterprise Value
8.56B
Revenue
908.35M
Ranking
n/a
PE Ratio
17.48
Stock Price
12.64
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 10.56B, an increase of 24.84%. That is a compound annual growth rate of 4.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 10.56B | 3.89% |
| Dec 31, 2025 | 10.17B | 646.35% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 16.92B |
| Zai Lab | 15.80B |
| Nanjing Leads Biolabs | 14.82B |
| Everest Medicines | 13.50B |
| CStone Pharmaceuticals | 12.27B |
| Lepu Biopharma | 10.10B |
| CARsgen Therapeutics Holdings | 9.70B |
| Guangzhou Innogen Pharmaceutical Group | 9.55B |